Lung Cancer

As per available reports about 6 journals, 162 Conferences, 21 workshops are presently dedicated exclusively to Lung Cancer and about 165,000 articles are being published on the current trends in Lung Cancer. In terms of research annually, USA, India, Japan, Brazil and Canada are some of the leading countries where maximum studies related to proteomics are being carried out. Cancer is a pathological condition, where assemblage of cells displays uncontrolled growth, invasion and sometimes metastasis. Starting from diagnosis, therapy, and post therapy procedures, cancer treatment involves various Medical, Clinical, Pathological, Psychological approaches with several implications. Cancer research hence is an ever growing literature with the advancement of new therapeutic solutions to prevent, handle and fight it effectively.

The Cancer Science & Therapy is an academic journal – hosted by OMICS International – a pioneer in open access publishing–and is listed among the top 10 journals in Lung Cancer. Each year research scientists have noticed a rise in the number of congresses being held in this field. The Cancer Science & Therapy provides a unique platform to researchers and scientist to explore the advanced and latest research developments in the field of Lung Cancer, thus bridging the gap between researchers and young scientists.

OMICS International – a pioneer in organizing international conferences (Cancer Science-2014 anticipating more than 300 thought provoking presentations and eminent Keynote lectures. The attending delegates from renowned organizations, Societies and Editorial Board Members of featured OMICS Group Journals. This International conference is an excellent opportunity for the participants from Universities and Institutes to interact with the World class Scientists and renowned speakers. The scientific sessions of the Cancer Science conferences housing the current research in cancer research. Tumor science will host presentations related to Tumor Microenvironment, communication, and Tumor progression. Cancer therapeutics will focus on translating cancer biology research into novel oncology treatments).